Boston Globe Abbott Says Humira Gained Market Share in Crohn's, PsoriasisBloombergPhotographer: Tim Boyle/Bloomberg Revenue from Abbott Laboratories (ABT)' top-selling drug, Humira, surged 25 percent after wresting sales from rival treatments for psoriasis and Crohn's disease, Chief Financial Officer Thomas Freyman said. …Abbott Says Humira Gained Market Share in Crohn's, PsoriasisSan Francisco ChronicleAbbott Labs 2Q profit [...]
Abbott Says Humira Gained Market Share in Crohn’s, Psoriasis – Bloomberg
July 25th, 2011 · No Comments
Tags: Top News
Similac Recall 2010, 5 Million Products Affected
September 23rd, 2010 · No Comments
Today, Abbott Laboratories announced that they have issued a massive recall of their product Similac infant-formula, as it has been found out these products may be contaminated with insect parts! The insects were found in a section of their manufacturing plant in Sturgis, Michigan. Melissa Brotz, Abbott’s spokeswoman said: “We immediately shut down that one [...]
Tags: Word on The Street
Pre-Market Outlook; U.S. Equity Market AVAV, AGN, AEO, PSS, FACT – Benzinga
March 10th, 2010 · No Comments
Pre-Market Outlook; U.S. Equity Market (AVAV, AGN, AEO, PSS, FACT)BenzingaFacet Biotech Corporation (NASDAQ: FACT) surged by 67% in afterhours trading after Abbott Laboratories (NYSE: ABT) reached an agreement to buy the …
Tags: Lead Stories
